PIH & Uneven Skin Tone: Rethinking Management Through
Multi‑Pathway Control

Our Faculty

Dr Farida Modi

MD
Consultant Dermatologist and Cosmetologist, DermaCare, Mumbai

Dr Valerie D. Callender

MD
Founder & Medical Director, Callender Dermatology & Cosmetic Center; Founder & Principal Investigator, Callender Center for Clinical Research, Washington

Prof. B S Chandrashekar

MD
DNB (Derma) Chief Dermatologist & Managing Director – CUTIS Academy, Bengaluru Chairman – CUTIS Group

LEARNING OBJECTIVES

• Reframing everyday pigmentation: Highlight how the majority of cases in clinical practice are PIH and uneven skin tone rather than classic melasma.
• Why current approaches often fall short: Limitations of single-pathway treatments and over-reliance on aggressive therapies, with a gap in long-term, tolerable management.
• PIH as a multi-pathway condition:
  • Melanin production
  • Inflammation
  • Epidermal turnover and barrier function
• Need for a multi-pathway approach: The importance of addressing these mechanisms simultaneously to achieve better and more sustained outcomes.
• Practical clinical application:
  • Early intervention, especially post-acne or post-inflammation
  • Importance of daily-use, well-tolerated regimens
  • Role of consistency and patient compliance
• Managing uneven skin tone: Moving beyond spot treatment to overall tone correction and uniformity, which is increasingly a key patient concern.
• Clinical experience / evidence: Case-based insights or experience with multi-active formulations in PIH and uneven tone would be extremely valuable.

Agenda

Copyright: All rights reserved. No part of this website content may be reproduced, stored in retrieval system, tapes, discs, microfilms etc., or transmitted in any form or by any means electronic, mechanical, photocopies, recording or otherwise, without the written permission of Insignia Learning Pvt. Ltd., Mumbai.